BrandWikiReturn

Patanjali Ayurved

Patanjali Ayurved is an Indian multinational conglomerate holding company, based in Haridwar. It was founded by Ramdev and Balkrishna in 2006.[5] Its office is in Delhi, with manufacturing units and headquarters in the industrial area of Haridwar.[6] The company manufactures cosmetics, ayurvedic medicine, personal care and food products.[7] The CEO of the company, with a 94-percent share hold, is Balkrishna. Ramdev represents the company and makes strategic decisions.[8][9][10] The company has faced various controversies over its misleading promotions and false claims for COVID-19 treatment.

History

Ramdev and Balkrishna established Patanjali Ayurved in 2006.[5][11][12] Balkrishna owns 94 percent of the company, and the remainder is dispersed among other individuals.[9] In May 2021, Balkrishna had a net worth of US$2.3 billion.[13]

According to CLSA and HSBC, Patanjali was one of the fastest-growing FMCG companies in India in 2016. It was valued at inr 30000000000.[14][15][16] Patanjali estimated its annual turnover for the 2016–17 fiscal year at .[17] In fiscal year 2022, Patanjali Ayurved posted revenues of Rs 10,664.46 crore.[18] According to a report by India Infoline (IIFL), at least 13 listed companies would be affected by Patanjali's success; they included Hindustan Unilever, Colgate, Dabur, ITC, and Godrej Consumer Products.[16]

In 2025, Patanjali Ayurved along with DS Group acquired Magma General Insurance for ₹4,500 crore. [19]

In December 2025, The Government of Tripura partnered with Patanjali Ayurved for a project in Tripura State worth Rs 300-400 crores.[20]

Patanjali Ayurved opened a hospital "Patanjali Emergency & Critical Care Hospital" on 22nd January 2026 which was inaugurated by home minister of India Amit Shah.[21]

In June 2025, Patanjali announced a mega food park project on 172.84 acres in Vizianagaram district. Andhra Pradesh Industrial Infrastructure Corporation (APIIC) had acquired ‘D' patta lands from farmers for the project.[22]

In December 2025, Patanjali partnerred with Russian Government to promote health & wellness and tourism.[23]

Revenue

Future Group, which has joined with Patanjali, sells about inr 300000000 worth of Patanjali products every month.[27][28][29]

Production

Patanjali Food and Herbal Park in Haridwar is the company's main production facility. With a production capacity of inr 350000000000, it is expanding to a capacity of inr 600000000000 through new production units in Noida, Nagpur, and Indore.[25][30][31]

In 2016, the Patanjali Food and Herbal Park received 35 full-time, armed Central Industrial Security Force (CISF) commandos.[32][33][34] The park will be the eighth private institute in India to be guarded by paramilitary CISF forces.[34]

Controversies

Patanjali Ayurved has had many cases filed against by the Government of Uttarakhand for various offences[35]

In June 2025, The Nainital High Court has quashed the criminal case against Patanjali Ayurveda Limited and its founders Baba Ramdev and Acharya Balkrishna for publishing misleading advertisements.[36]

Patanjali has been cited for its working conditions; Ramdev and Balkrishna are treated as gurus whose feet must be touched each time they enter an area. Workers are paid inr 6000 per month, working 12-hour shifts, six days a week. They are also discouraged from asking for a raise, with the rationale that working at the factory is considered "seva" (voluntary service) to the cause and is a payment in itself.[37][38][39]

On 22 May 2021, the Indian Medical Association (IMA) in Uttarakhand sent a defamation notice of inr 10000000000 after remarks by Ramdev about doctors who practise evidence-based medicine.[40][41] On 14 August 2025, Supreme Court, dismissed IMA's plea against Patanjali, upholds repeal of rule on AYUSH ads.[42]

Infertility cure

One of the products manufactured by Ramdev's Divya pharmacy and sold by the Patanjali Pharmacy chain was Divya Putrajeevak Seed, described in its catalog as a natural herb which (according to the company) could treat infertility. However, doctors pointed out the misleading name of the drug: the word "putrajeevak" ( "son's life" ). Some Patanjali Pharmacy stores sold the drug with the claim that it would ensure the birth of a boy, reportedly leading to an increase in sales.[43]

The issue was raised in the Indian Parliament in July 2015 by opposition members who accused Ramdev of "peddling a product which promised delivery of male children." The Ministry of AYUSH (which oversees the sale of alternative medicines) defended the product's name, saying that it was named after a herb.[44]

In 2016, the Uttarakhand health department said that the drug violated the Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994.[45] The Maharashtra government ordered a probe of whether the drug had violated laws in 2018, and Congress leaders in the state demanded a ban on the drug.[46]

Ganges pollution

In January 2018, villages in Haridwar district complained that Patanjali's Padarth factory was polluting a Ganges channel and other local rain-fed bodies of water with surface runoff; chemicals released by the factory reportedly killed several animals in the area. The local government took no action on the factory due to Ramdev's influence, and residents of 40 villages threatened agitation. The Uttarakhand Environment Conservation and Pollution Control Board ordered a clean-up of the waste flowing through the area. In the past, the board had notified Padarth about its release of untreated industrial effluent into local bodies of water. Patanjali's general manager denied the allegations, saying that the company followed established protocols.[47]

Amla juice

The Ministry of Defence canteen stores department (CSD) suspended Patanjali Ayurved's amla juice after receiving an adverse state laboratory test report on the product; the central food laboratory found the juice unfit for consumption. The CSD asked its depots to make debit notes for their existing stock, so the product could be returned.[48]

FSSAI notices

Patanjali introduced its instant noodles on 15 November 2015.[49][50][51] The Food Safety and Standards Authority of India notified the company that neither Patanjali nor Aayush, the brand names for which Patanjali obtained licenses, received approval for the manufacture of instant noodles.[52][53][54][55] In Rajasthan, mustard oil sold by Patanjali was found substandard by the FSSAI's Alwar laboratory.[56]

Ayush Ministry against false advertisements

Ministry of AYUSH has advised certain states to take necessary action against Baba Ramdev's Patanjali Ayurved for illegally promoting products that claimed to cure diabetes, heart and liver diseases. The Ministry has specifically sought action against the advertisements of three Patanjali products — Lipidom, Livogrit and Livamrit.[57][58][59]

Fake COVID-19 treatment

Patanjali Ayurved announced a drug named Coronil for COVID-19 treatment in June 2020, with Ramdev claiming that it cured the disease.[60][61][62] There was no clinical data to prove that the new drug was effective or even safe; this prompted a social-media backlash which questioned the role of the Ministry of AYUSH.[63] Within hours of Coronil's introduction, the ministry issued a statement denying authorisation for the new drug and asking the company to stop selling (and advertising) it until the trial results were examined by medical authorities.[64][65][66] An official from the ayurved department of the government of Uttarakhand said that the approval application for Coronil had not mentioned COVID-19.[67]

Laboratory tests showed that the drug did not contain any ingredients which could treat or prevent coronavirus infections. The Indian government allowed Patanjali Ayurved to market Coronil as an immunity booster (not a cure),[62] but the Government of Maharashtra has banned the sale of Coronil in the state. First information reports were filed in Bihar and Rajasthan against Ramdev, Balkrishna and others, accusing them of dishonesty and selling fake medicines.[68][69] Patanjali responded to the accusations, saying that they did not violate any procedures before the drug was launched.[70] A Madras High Court judge fined the company inr 1000000 for making false claims about the drug, and Patanjali withdrew its claim that Coronil could cure COVID-19. The UK drug regulator threatened action if unauthorized products were sold in the UK.[62]

The government of Maharashtra banned Coronil in the state in June 2020, with home minister Anil Deshmukh threatening the company with legal action if they did not observe the ban.[71] The Madras High Court also barred Patanjali Ayurved from using the name "Coronil".[72][73] The court's order came while it heard a suit filed by a Chennai-based firm which said that it had owned the trademark "Coronil" since 1993. Making an earlier interim injunction against Patanjali absolute, Madras High Court Justice C. V. Karthikeyan also imposed the fine on the company.[74][75] In his ruling, the judge observed that Patanjali had been "chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the coronavirus when their 'Coronil Tablet' is not a cure".[76][72][77] Nepal and Bhutan halted the distribution of donated Coronil after orders from their governments to disclose that it was not a medicine to cure COVID-19.[78][79]

False claims of government and WHO approvals

In February 2021, The Indian Express, The Times of India, The Hindu and Livemint reported Patanjali Ayurved's claim that Coronil had been approved by the Ministry of AYUSH and certified by the World Health Organization. The reports indicated that Ramdev had released studies showing that Coronil was effective against COVID-19 at a press conference attended by Union Health Minister Harsh Vardhan and transport minister Nitin Gadkari.[80][81][82][83] In a News Nation interview, Ramdev accused doctors of "allopathic terrorism" for doubting Coronil's effectiveness.[84] The claim was endorsed by Bharatiya Janata Party spokesperson Sanju Verma, who called it "... a huge endorsement for Ayurveda India's homegrown StartUp ecosystem that has flourished under @narendramodi govt."[84] Verma described the approvals granted to Coronil as a "slap in the face" to the BJP's opposition.[85]

On 22 February, the WHO said that it had not "... reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19."[86] Several news and fact-checking outlets, including The Wire, Alt News, BBC News and The Economic Times, ran fact-checking articles debunking Ramdev and Patanjali's claims; Coronil had received an export license, and had not received any approval regarding its effectiveness as a treatment against COVID-19.[87][88][84][89] Patanjali Ayurveda CEO Balkrishna admitted on Twitter that the approval for Coronil had not come from the WHO or the Ministry of AYUSH (as they had claimed), but had been granted by the Drugs Controller General of India for export – not as a certification of effectiveness.[84][87]

False claims of government and WHO approvals

In February 2021, The Indian Express, The Times of India, The Hindu and Livemint reported Patanjali Ayurved's claim that Coronil had been approved by the Ministry of AYUSH and certified by the World Health Organization. The reports indicated that Ramdev had released studies showing that Coronil was effective against COVID-19 at a press conference attended by Union Health Minister Harsh Vardhan and transport minister Nitin Gadkari.[80][81][82][83] In a News Nation interview, Ramdev accused doctors of "allopathic terrorism" for doubting Coronil's effectiveness.[84] The claim was endorsed by Bharatiya Janata Party spokesperson Sanju Verma, who called it "... a huge endorsement for Ayurveda India's homegrown StartUp ecosystem that has flourished under @narendramodi govt."[84] Verma described the approvals granted to Coronil as a "slap in the face" to the BJP's opposition.[85]

On 22 February, the WHO said that it had not "... reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19."[86] Several news and fact-checking outlets, including The Wire, Alt News, BBC News and The Economic Times, ran fact-checking articles debunking Ramdev and Patanjali's claims; Coronil had received an export license, and had not received any approval regarding its effectiveness as a treatment against COVID-19.[87][88][84][89] Patanjali Ayurveda CEO Balkrishna admitted on Twitter that the approval for Coronil had not come from the WHO or the Ministry of AYUSH (as they had claimed), but had been granted by the Drugs Controller General of India for export – not as a certification of effectiveness.[84][87]

Taking control over Dalits' lands

In August 2022, Newslaundry published a report alleging that Patanjali took control of Dalits' lands for cow shelter and herb farms in Teliwala village, Uttarkhand through force and circumvention of laws, making people there landless.[90]

Accusations of using fish bones in veg product

In May 2023, a Delhi-based law firm issued a legal notice to Patanjali Ayurved accusing the company of using 'cuttlefish bones' in dental care product, branding non-veg product as vegetarian in violation of the law.[91]

Misleading advertising case

The company has been accused of misleading advertising[92][93] about its products and flimsy testing before being marketed.[94] Between April 2015 and July 2016, 33 complaints were received against 21 misleading advertisements; seventeen violated ASCI standards.[95] In September 2017, the Delhi High Court ordered the company to stop airing an advertisement for its brand of chyavanprash which disparaged a competitor's.[96] Company products, such as amla juice[97][98] and ayurvedic medicines[99] have been banned for poor quality.[98][100]

Patanjali was sued by the Indian Medical Association in August 2022 for attacking allopathy to promote its medicines, violating DOMA and the Consumer Protection Act, 2019. The Supreme Court accused Patanjali of misleading marketing in November 2023 and threatened a Rs 1 crore per product fine for bogus promises.[101][102]

In February 2024, the Supreme Court banned Patanjali's commercials and found Balkrishna in contempt. Patanjali was forced to apologize in newspapers by the Supreme Court. Patanjali apologized, but the court considered them insufficient. Patanjali issued more newspaper apologies per court ruling. The Uttarakhand Licensing Authority revoked 14 Patanjali product licenses after Supreme Court investigation of regulatory inaction.[103][104]

In August 2024, the Supreme Court closed contempt proceedings against Patanjali Ayurved co-founders Baba Ramdev and Acharya Balkrishna, and their company in the misleading advertisements case, accepting the apology tendered by the parties after they took steps to rectify their mistake. The top court, however, warned that both Ramdev and Balkrishna should comply with all future orders and not repeat their past conduct.[105][106]

Products

Patanjali Ayurved produces cosmetics and personal-care, ayurvedic and food products.[107][108][109] The company opened Patanjali Paridhan, a clothing store in Delhi, in November 2018.[110]

Sales and distribution

In May 2016, the company had nearly 4,700 retail outlets.[108][111] Patanjali also sells its products online, and is planning to open outlets at railway stations and airports.[112] The company joined Pittie Group and Kishore Biyani's Future Group on 9 October 2015,[108] making its products available in Future Group outlets.[113][114][115] Patanjali Ayurveda products are also available at Reliance Retail, Hyper City and Star Bazaar.[108][116][117][118][119] The company had a target revenue of inr 100000000000 revenue in 2016–17, after sales increased by 150 percent in the previous financial year to inr 50000000000.[120]

Patanjali Ayurved's advertisement and sales promotion expenses in FY24 rose by 145.46% compared to FY23, increasing from Rs 173.13 crore to Rs 424.7 crore[121]

Acquisition

In December 2019, Patanjali reportedly acquired bankrupt Ruchi Soya Industries for inr 43500000000.[122]

See also

  • FMCG in India

External links

References

  1. Patanjali CEO Acharya Balkrishna Among India's Richest: ChaMagazine NDTV, 18 September 2016, retrieved 10 January 2017^
  2. Patanjali to launch 'Swadeshi' jeans soon, exploring global markets with FMCG Firstpost, 12 September 2016, retrieved 4 December 2016^
  3. Patanjali Ayurved clocked 14% jump in profit in FY21: Tofler data 2023^
  4. Patanjali Ayurved Tracxn, 4 May 2024, retrieved 9 May 2024^
  5. Megha Bahree. India's Baba Ramdev Billionaire Is Not Baba Ramdev Forbes, 26 October 2016, retrieved 16 February 2017^
  6. Purusharth Aradhak. 430 acres allotted to Patanjali The Hindu, retrieved 26 February 2017^
  7. Robert F. Worth. The Billionaire Yogi Behind Modi's Rise The New York Times, 2018-07-26, retrieved 2021-07-13^
  8. Jwalit Vyas. Baba Ramdev's Patanjali starts to take a toll on some FMCG firms The Economic Times, 29 February 2016^
  9. Baba Ramdev is just the face, it's Acharya Balakrishna who is behind Patanjali's Rs 10,561 cr turnover Business Today, 4 May 2017, retrieved 30 May 2021^
  10. Stephanie Findlay, Jyotsna Singh. India's yogi tycoon angers critics with coronavirus 'cure' kit Financial Times, 6 August 2020^
  11. Baba Ramdev's Business Empire Soars, With His Own Rising Profile HuffPost India, retrieved 18 January 2015^
  12. Avishek Rakshit. The Patanjali effect Business-Standard, 8 February 2016^
  13. Forbes profile: Acharya Balkrishna Forbes, retrieved 30 May 2021^
  14. Are PEs bending over backwards to invest in Patanjali? The Hindu, 11 January 2016^
  15. Patanjali is disrupting India's consumer space IIFL, 6 February 2016, retrieved 7 February 2016^
  16. HSBC Global Rsearch [sic] cuts target prices of Britannia Dabur and Nestle between 6% and 16%, says Patanjali Economic Times, 5 February 2016, retrieved 7 February 2016^
  17. Arnab Dutta. Ramdev's Patanjali shakes up FMCG order; next up 'nutritious restaurants' Business Standard, 5 May 2017, retrieved 15 July 2017^
  18. Arshad Khan. Patanjali to list 4 firms in next 5 years The New Indian Express, 2022-09-17, retrieved 2026-03-31^
  19. Patanjali Ayurved, DS Group to acquire Magma General Insurance for ₹4,500 crore The Hindu, 13 March 2025^
  20. Tripura government sign MOU with Patanjali Ayurved for project in Tripura tripurainfo DOT com^
  21. Patanjali launches India’s first hybrid hospital for heart, brain and spine care The Times of India, 22 January 2026^
  22. Patanjali Group to revive mega food park project in Vizianagaram district The Times of India, 27 June 2025^
  23. Patanjali Group signs MoU to enter Russia with its Ayurveda products, promote health & wellness The Economic Times, 6 December 2025^
  24. Patanjali sales growth grinds to a halt in FY18 Livemint, 18 May 2018^
  25. Patanjali and its grand plans: Ramdev expects Rs 20,000 cr revenue in FY18 Business Standard, 4 May 2017^
  26. Patanjali reports Rs 8,339 crore revenue in FY 19; food items account for 62% of total sales Business Today, 19 November 2019, retrieved 20 December 2019^
  27. Baba Ramdev's Patanjali Group compels FMCG firms Hindustan Unilever and Dabur to expand portfolio IBT Times, 26 January 2016, retrieved 7 February 2016^
  28. http://www.india.com/news/india/patanjali-ayurved-doubles-its-profit-in-one-year-set-to-catch-up-with-rivals-1051546/ Patanjali Ayurved doubles its profit in one year; set to catch up with rivals^
  29. Sounak Mitra. Inside Baba Ramdev's Patanjali empire livemint, 3 June 2016, retrieved 18 December 2022^
  30. Ramdev to open herbal factory in Nepal Web Dunia, 18 April 2015^
  31. Patanjali herbal park in Nepal Insight TV News Network, 28 February 2015, retrieved 29 October 2015^
  32. Yatish Yadav. CISF Team to Guard Ramdev's Food Park Indian Express, 9 March 2016^
  33. Varun Sharma. Ramdev's Food Park Gets Round-The-Clock Protection From Paramilitary CISF NDTV, 8 March 2016, retrieved 9 March 2016^
  34. Ramdev's food park gets full-time CISF cover The Tribune India, 9 March 2016^
  35. Shishir Prashant. With BJP in power, focus is now on cases against Baba Ramdev Business Standard India, 20 March 2017, retrieved 21 December 2020^
  36. Uttarakhand News: पतंजलि, बाबा रामदेव और आचार्य बालकृष्ण के खिलाफ आपराधिक मामला रद्द, जानिये मामला Amar Ujala^
  37. Baba Ramdev: Inside Patanjali: Here's what life is like in Baba Ramdev's company The Economic Times, retrieved 2022-10-10^
  38. Priyanka Pathak-Narain. Patanjali believes its staff does 'seva': Ex-CEO S.K. Patra mint, 2017-08-04, retrieved 2021-05-10^
  39. Baba Ramdev wants employees to work for free: A former CEO reveals the Patanjali story The New Indian Express (newspaper), 4 August 2017^
  40. 'Criminal act': Ramdev gets ₹1,000 cr defamation notice from IMA Uttarakhand Hindustan Times, 2021-05-26, retrieved 2021-05-26^
  41. IMA Uttarakhand sends Rs 1,000-cr defamation notice to Ramdev over remarks on allopathy www.businesstoday.in, 26 May 2021, retrieved 2021-05-26^
  42. SC dismisses IMA's plea against Patanjali, upholds repeal of rule on AYUSH ads The Times of India, 14 August 2025^
  43. In Name of Ramdev's Infertility Cure, the Promise of a Boy Child? NDTV.com, retrieved 21 December 2020^
  44. Ramdev's 'Putrajeevak beej' is named after herb: AYUSH minister Business Standard India, 26 May 2015, retrieved 21 December 2020^
  45. Shivani Azad. U'khand says Ramdev's fertility pill 'Putrajeevak Beej' violates PNDT Act The Times of India, 2 February 2018, retrieved 21 December 2020^
  46. Yogesh Naik. Govt to probe sale of controversial Patanjali product Mumbai Mirror, 21 July 2018, retrieved 21 December 2020^
  47. Villagers say Patanjali unit polluting water bodies in Haridwar Hindustan Times, 23 January 2018, retrieved 21 December 2020^
  48. Defence canteens remove Ramdev's Patanjali amla juice after adverse lab report retrieved 18 May 2020^
  49. Ramdev's Patanjali launches noodles The Hindu, 16 November 2015, retrieved 19 November 2015^
  50. FSSAI sends notice to Baba Ramdev's company ibnlive.com, 21 November 2015^
  51. Trouble mounts for Ramdev's Atta Noodles, FSSAI issues notice to Patanjali Ayurved Navbharat Times^
  52. No Approval for Patanjali Instant Noodles, Says Food Safety Regulator NDTV, 18 November 2015^
  53. 'No licence for noodles': FSSAI slaps showcause on Patanjali The Indian Express, 21 November 2015^
  54. Patanjali's Atta Noodles in trouble: Baba Ramdev breaks silence, drags Modi govt into controversy oneindia.com, 19 November 2015^
  55. Patanjali Atta noodles gets notice livehindustan.com, retrieved 13 January 2016^
  56. Sharat Kumar. Patanjali mustard oil found to be of substandard food quality: Rajasthan govt India Today, June 10, 2021, retrieved 2021-06-30^
  57. Patanjali ads claiming to cure heart, liver issues come under govt scanner The News Minute, 2022-04-27, retrieved 2022-04-28^
  58. AYUSH Ministry seeks action against advertisements by Ayurveda pharma The Hindu, 2022-04-24, retrieved 2022-04-28^
  59. Glare on Patanjali for heart and liver products advertisements www.telegraphindia.com, retrieved 2022-04-28^
  60. Ravi Prakash Kumar. Coronavirus treatment: Ramdev's Patanjali launches Coronil kit for ₹545 Livemint, 2020-06-23, retrieved 2020-06-24^
  61. Baba Ramdev's Patanjali launches Ayurvedic medicine Coronil for coronavirus! All you need to know The Financial Express, 2020-06-23, retrieved 2020-06-24^
  62. Covid-19: Fake 'immunity booster' found on sale in London shops BBC News, 19 December 2020, retrieved 21 December 2020^
  63. Kavya Narayanan. AYUSH Ministry is endangering people, jeopardising Ayurveda with lax response to Patanjali's Coronil and COVID-19, warn experts Firstpost, 28 June 2020, retrieved 29 June 2020^
  64. Govt asks Patanjali to stop ads of Covid drug Hindustan Times, 2020-06-23, retrieved 2020-06-24^
  65. Ramdev's Patanjali Asked By Government To Explain COVID Drug Claim NDTV.com, retrieved 2020-06-24^
  66. Ayush Ministry Stops Patanjali From Selling, Advertising Purported Covid Medicine BloombergQuint, 23 June 2020, retrieved 2020-06-24^
  67. Patanjali's Coronil approval application did not mention coronavirus: Licence officer India Today, 24 June 2020, retrieved 29 June 2020^
  68. Jasra Afreen. Complaint filed in Bihar court against Baba Ramdev over Covid-19 medicine claim Hindusthan Times, 29 June 2020, retrieved 29 June 2020^
  69. FIR against 5 over Covid-19 'medicine' claim: Ramdev, Patanjali MD booked for 'cheating' Indian Express, 29 June 2020, retrieved 29 June 2020^
  70. Abhinav Sahay. 'All parameters met': Patanjali claims Coronil clinical trial details furnished to Centre Hindusthan Times, 24 June 2020, retrieved 29 June 2020^
  71. Sonu Shrivastava. Maharashtra bans Patanjali's COVID-19 medicine 'Coronil' Asian Age, 26 June 2020, retrieved 29 June 2020^
  72. Apoorva Mandhani. Patanjali can't use Coronil trademark, says Madras High Court, fines it Rs 10 lakh ThePrint, 2020-08-06, retrieved 2021-02-18^
  73. Shalini Lobo. Patanjali chased profits by exploiting public fear: Madras HC imposes Rs 10 lakh fine on firm India Today, August 6, 2020, retrieved 2021-02-18^
  74. Madras HC: Patanjali cannot use 'Coronil' branding, must pay Rs 10 lakh fine for exploiting fear cnbctv18.com, 6 August 2020, retrieved 2021-02-18^
  75. Patanjali exploited public fear says Madras HC, imposes Rs 10 lakh fine The News Minute, 2020-08-06, retrieved 2021-02-18^
  76. Patanjali Ayurved fined Rs 10 lakh by Madras HC for chasing profits by claiming COVID-19 'cure' The New Indian Express, 6 August 2020, retrieved 2021-02-18^
  77. Patanjali Fined Rs 10 Lakh by Madras HC for Chasing Profits amid Covid-19 Fear, Using Coronil Trademark News18, 2020-08-06, retrieved 2021-02-18^
  78. Kallol Bhattacherjee. Nepal stops distribution of Coronil kits gifted by Patanjali The Hindu, 2021-06-08, retrieved 2021-06-30^
  79. Geeta Mohan. Nepal stops distribution of Coronil kits gifted by Patanjali, cites lack of proof on efficacy India Today, June 9, 2021, retrieved 2021-06-30^
  80. Coronil has received AYUSH certification as per WHO norms: Patanjali The Indian Express, 2021-02-20, retrieved 2021-02-21^
  81. Coronil has received Ayush Ministry certification as per WHO scheme: Patanjali mint, 2021-02-19, retrieved 2021-02-21^
  82. Patanjali Coronil: Coronil gets Ayush ministry certification as per WHO scheme: Patanjali The Times of India, 19 February 2021, retrieved 2021-02-21^
  83. Coronil gets Ayush Ministry certification as 'supporting measure' for COVID-19 treatment The Hindu, 2021-02-19, retrieved 2021-02-21^
  84. Pooja Chaudhuri. Fact Check: Patanjali's Coronil Neither WHO Certified nor Approved The Wire Science, 2021-02-21, retrieved 2021-02-21^
  85. Tweet: @Sanju_Verma Twitter, 19 February 2021^
  86. Prashasti Awasthi. WHO clarifies it hasn't reviewed or certified Coronil for Covid-19 treatment @businessline, 21 February 2021, retrieved 2021-02-21^
  87. Ratna Bhushan. Patanjali's Coronil not WHO certified or approved; no traditional medicine certified by WHO for Covid cure The Economic Times, retrieved 2021-02-21^
  88. Patanjali's Coronil is neither WHO certified nor approved, media outlets run false news Alt News, 2021-02-20, retrieved 2021-02-21^
  89. Shruti Menon. Coronavirus: The misleading claims about an Indian remedy BBC Reality Check, 2 March 2021, retrieved 26 May 2021^
  90. Basant Kumar. How Ramdev's Patanjali took control of Dalit lands in Haridwar Newslaundry, 2022-08-19, retrieved 2022-08-31^
  91. Sumi Sukanya Dutta. Patanjali gets legal notice for using 'cuttlefish bones' in dental care product marked vegetarian ThePrint, 2023-05-18, retrieved 2023-05-18^
  92. Patanjali Advertisements Unsubstantiated, Misleading: Watchdog NDTV.com, 4 July 2016, retrieved 2021-05-02^
  93. Patanjali Ayurved Rapped For Misleading Hair Oil, Other Advertisements NDTV.com, 26 May 2016, retrieved 2021-05-02^
  94. Ramdev's Patanjali products fail quality test, RTI inquiry finds Hindustan Times, 2017-05-29, retrieved 2020-10-07^
  95. 33 Complaints Received Against Patanjali Advertisements NDTV.com, 2 August 2016, retrieved 2021-05-02^
  96. Delhi Court Restrains Patanjali From Airing Ads Promoting Chyawanprash NDTV.com, 7 September 2017, retrieved 2021-05-02^
  97. Sandhya Dangwal. CSD withdraws Baba Ramdev's popular product after lab declares it unfit for consumption India News, Breaking News, Entertainment News, 2017-04-24, retrieved 2020-10-07^
  98. Military Canteens Ban sales of Patanjali Amla Juice Saying Truth, 2017-04-24, retrieved 2020-10-07^
  99. Nepal drug administration reject six Patanjali products after tests, contain pathogenic bacteria Firstpost, 2017-06-22, retrieved 2020-10-07^
  100. Ramdev's Patanjali products fail quality test, RTI inquiry finds Hindustan Times, 30 May 2017, retrieved 21 December 2020^
  101. Saumya Kalia. Supreme Court's ban on Patanjali ads The Hindu, 3 March 2024, retrieved 25 May 2024^
  102. Krishnadas Rajagopal. Supreme Court issues contempt notice to Patanjali, its MD Balkrishna The Hindu, 27 February 2024, retrieved 28 February 2024^
  103. After Supreme Court rap, Patanjali issues another public apology — bigger in size Indian Express, 24 April 2024, retrieved 25 May 2024^
  104. Supreme Court not impressed with Uttarakhand authority's 'lightning' action to suspend 14 licences of Patanjali, Divya Pharmacy The Hindu, 30 April 2024, retrieved 25 May 2024^
  105. Supreme Court closes contempt case against Patanjali Ayurved, co-founders^
  106. Patanjali ads: Relief for Ramdev, Acharya Balakrishna as Supreme Court closes contempt case^
  107. Ramdev turns his Ayurved enterprise into an FMCG empire 28 June 2015^
  108. Here's Why Baba Ramdev Is Making Corporate India Uncomfortable Indiatimes, 13 January 2015, retrieved 14 January 2024^
  109. We plan to open Patanjali outlets at Railway stations, airports: Ramdev 21 May 2015, retrieved 20 June 2015^
  110. Sonam Saini. Patanjali's fashion foray: Baba Ramdev's company turns to apparel after creating ripples in FMCG Financial Express, 18 February 2019, retrieved 26 May 2021^
  111. Baba Ramdev expands empire beyond yoga to FMCG The Economic Times, 13 January 2015, retrieved 18 January 2015^
  112. Ramdev's Patanjali Ayurved enters big retail with Future Group tie-up India Today^
  113. Ramdev products available in Big bazaar Nayi Duniya, 9 October 2015^
  114. Future group and Patanjali tie-up Patrika, 9 October 2015^
  115. Future Group partners Patanjali Ayurveda The Hindu, 9 October 2015, retrieved 14 October 2015^
  116. Patanjali products to be sold in Khadi bhandars Amar Ujala, 18 December 2014^
  117. Baba Ramdev's Patanjali Ayurveda to make, sell DRDO food products ABP Live, 25 August 2015^
  118. Baba Ramdev's Patanjali Ayurveda To Sell DRDO Food Products HuffPost India, 24 August 2015^
  119. "Patanjali Ayurved to invest Rs 1,150 crores, eyes doubling revenue" The Hindu^
  120. Arnab Dutta. Baba Ramdev's Patanjali aims to double its revenue to Rs 10,000 cr in 2016-17 Business Standard India, 27 April 2016, retrieved 16 March 2018^
  121. afaqs! news bureau. Patanjali's ad spends increase by 145% YoY to Rs 424.7 crore in FY2024 afaqs!, 2024-09-05, retrieved 2024-09-05^
  122. Patanjali Completes Acquisition Of Ruchi Soya BloombergQuint, 18 December 2019, retrieved 2020-05-02^